Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Cash from Financing Activities (2019 - 2025)

Bioadaptives' Cash from Financing Activities history spans 7 years, with the latest figure at $255000.0 for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $255000.0 for Q4 2025, up 31.37% from a year ago — trailing twelve months through Dec 2025 was $549115.0 (up 18.8% YoY), and the annual figure for FY2025 was $555000.0, up 70.14%.
  • Cash from Financing Activities for Q4 2025 was $255000.0 at Bioadaptives, up from $194115.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $255000.0 in Q4 2025 to a low of $30000.0 in Q3 2021.
  • The 5-year median for Cash from Financing Activities is $75000.0 (2021), against an average of $93460.5.
  • The sharpest move saw Cash from Financing Activities surged 496.09% in 2021, then plummeted 57.49% in 2022.
  • Year by year, Cash from Financing Activities stood at $52000.0 in 2021, then crashed by 35.81% to $33377.0 in 2022, then soared by 403.64% to $168100.0 in 2023, then increased by 15.48% to $194115.0 in 2024, then surged by 31.37% to $255000.0 in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $255000.0, $194115.0, and $100000.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.